1. Home
  2. RNST vs TVTX Comparison

RNST vs TVTX Comparison

Compare RNST & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNST

Renasant Corporation

HOLD

Current Price

$40.49

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$40.20

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNST
TVTX
Founded
1904
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.8B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
RNST
TVTX
Price
$40.49
$40.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
14
Target Price
$42.25
$40.46
AVG Volume (30 Days)
597.1K
2.3M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
2.27%
N/A
EPS Growth
N/A
92.89
EPS
2.07
N/A
Revenue
N/A
N/A
Revenue This Year
$31.72
$43.88
Revenue Next Year
$4.67
$33.16
P/E Ratio
$19.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.85
$13.88
52 Week High
$42.11
$43.31

Technical Indicators

Market Signals
Indicator
RNST
TVTX
Relative Strength Index (RSI) 69.58 68.21
Support Level $35.26 $32.62
Resistance Level $42.11 $41.44
Average True Range (ATR) 1.00 2.21
MACD 0.36 1.17
Stochastic Oscillator 89.27 79.70

Price Performance

Historical Comparison
RNST
TVTX

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: